Decrease in cerebral free magnesium concentration following closed head injury and effects of VA-045 in rats

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Cerebral free magnesium (Mg2+) plays a crucial role in neuronal function and injury response.
• Closed head injury (CHI) is a common cause of traumatic brain injury with significant neurological consequences.
• Understanding the dynamic changes in brain Mg2+ following CHI is essential for developing effective therapeutic strategies.

Purpose of the Study:

• To investigate the alterations in cerebral free Mg2+ concentration in a rat model of CHI.
• To evaluate the neuroprotective effects of VA-045, a novel apovincaminic acid derivative, on cerebral Mg2+ levels post-CHI.

Main Methods:

• Utilized in vivo 31P-Nuclear Magnetic Resonance (NMR) spectroscopy to measure cerebral free Mg2+ concentrations in rats.
• Administered VA-045 to assess its impact on Mg2+ levels before and after inducing CHI.
• Compared Mg2+ levels in injured rats treated with VA-045 to control groups.

Main Results:

• Cerebral free Mg2+ decreased by approximately 30% within 20 minutes after head impact, further declining to about 60% of control levels after 3 hours.
• VA-045 administration significantly inhibited the reduction in cerebral free Mg2+ following CHI.
• VA-045 did not affect cerebral free Mg2+ levels in non-impacted rats, indicating a specific effect on injury-induced changes.

Conclusions:

• The observed decrease in cerebral free Mg2+ following CHI may be a critical factor contributing to irreversible brain tissue injury.
• VA-045 demonstrates potential as a therapeutic agent to prevent CHI-induced Mg2+ depletion and subsequent neuronal damage.
• Further research into VA-045's mechanism of action and clinical efficacy is warranted for traumatic brain injury treatment.